Scholarlink

<p>Venturicidin A (<b>1</b>) constitutes a glycosylated macrolide endowed with potent antifungal activity; however, the discrete contributions of its post-polyketide synthase modifications to bioactivity have remained elusive. Here we systematically deconvolute the structure–activity relationships of venturicidin A&#xa0;(<b>1</b>), its glycosylated congener venturicidin B&#xa0;(<b>2</b>), and the aglycon derivative venturicidin X&#xa0;(<b>3</b>). The latter was generated through targeted disruption of the glycosyltransferase-encoding gene&#xa0;<i>vtdG</i>.&#xa0;Across a panel of eight phytopathogenic fungal species, the glycosylated congeners exhibit markedly superior antifungal activity relative to the aglycon, with <b>1</b> outperforming the commercial fungicide carbendazim against&#xa0;<i>Alternaria alstroemeriae</i>&#xa0;CGMCC 3.1640. Mechanistically, glycosylation critically dictates the extent of plasma membrane disruption and mitochondrial impairment, whereas the carbamoyl moiety contributes negligibly to these phenotypes. Collectively, these findings establish the glycosyl moiety as&#xa0;an indispensable structural determinant of antifungal potency, furnishing a strategic blueprint for the rational optimization of venturicidin analogues.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Biosynthetic glycosylation as a critical structural determinant of antifungal activity in venturicidin A

  • 期刊论文

  • 发表日期：

    2026年6月15日

查看全文
  • Jiaozhuang Liu,
  • Liangting Liu,
  • Chunya Xie,
  • Zhi Qiao,
  • Xinyu Liu,
  • Yan-Bin Teng,
  • Gang Liu,
  • Zhenbin Zhou,
  • Qi Chen

摘要

Venturicidin A (1) constitutes a glycosylated macrolide endowed with potent antifungal activity; however, the discrete contributions of its post-polyketide synthase modifications to bioactivity have remained elusive. Here we systematically deconvolute the structure–activity relationships of venturicidin A (1), its glycosylated congener venturicidin B (2), and the aglycon derivative venturicidin X (3). The latter was generated through targeted disruption of the glycosyltransferase-encoding gene vtdG. Across a panel of eight phytopathogenic fungal species, the glycosylated congeners exhibit markedly superior antifungal activity relative to the aglycon, with 1 outperforming the commercial fungicide carbendazim against Alternaria alstroemeriae CGMCC 3.1640. Mechanistically, glycosylation critically dictates the extent of plasma membrane disruption and mitochondrial impairment, whereas the carbamoyl moiety contributes negligibly to these phenotypes. Collectively, these findings establish the glycosyl moiety as an indispensable structural determinant of antifungal potency, furnishing a strategic blueprint for the rational optimization of venturicidin analogues.